Routine laboratory claims review policies
- F2019 Flow Cytometry
- G2005 Vitamin D Testing
- G2006 Hemoglobin A1c
- G2007 Prostate Biopsies
- G2008 Prostate Specific Antigen (PSA) Testing
- G2011 Diagnostic Testing of Iron Hemostasis & Metabolism
- G2013 Testosterone
- G2014 Vitamin B12 and Methylmalonic Acid Testing
- G2022 ANA ENA Testing
- G2031 Allergen Testing
- G2035 Prenatal Screening (Nongenetic)
- G2036 Hepatitis C
- G2042 Pediatric Preventive Screening
- G2043 Celiac Disease Testing
- G2044 Helicobacter pylori Testing
- G2045 Thyroid Disease Testing
- G2048 Biochemical Markers Of Alzheimer Disease and Dementia
- G2050 Cardiovascular Disease Risk Assessment
- G2051 Bone Turnover Markers Testing
- G2055 Prenatal Screening for Fetal Aneuploidy
- G2056 Diagnosis of Idiopathic Environmental Intolerance
- G2059 Epithelial Cell Cytology in Breast Cancer Risk Assessment
- G2060 Fecal Analysis Diagnosis of Intestinal Dysbiosis and Fecal Microbiota Transplant Testing
- G2061 Fecal Calprotectin Testing in Adults
- G2063 Testing for Diagnosis of Active or Latent Tuberculosis
- G2098 Immune Cell Function Assay
- G2099 Intracellular Micronutrient Analysis
- G2100 In Vitro Chemoresistance and Chemosensitivity Assays
- G2105 Immunopharmacologic Monitoring of Therapeutic Serum Antibodies
- G2107 Measurement of Thromboxane Metabolites for ASA Resistance
- G2110 Serum Testing for Hepatic Fibrosis Evaluation and Monitoring of Chronic Liver Disease
- G2113 Oral Screening Lesion Identification Systems and Genetic Screening
- G2115 Metabolite Markers of Thiopurines Testing
- G2119 Diagnostic Testing of Influenza
- G2120 Salivary Hormone Testing
- G2121 Laboratory Testing for the Diagnosis of Inflammatory Bowel Disease
- G2123 Biomarker Testing for Multiple Sclerosis and Related Neurologic Diseases
- G2124 Serum Tumor Markers for Malignancies
- G2125 Urinary Tumor Markers For Bladder Cancer
- G2138 Evaluation of Dry Eyes
- G2143 Lyme Disease Testing
- G2149 Pathogen Panel Testing
- G2150 Cardiac Biomarkers for Myocardial Infarction
- G2153 Ancreatic Enzyme Testing for Acute Pancreatitis
- G2154 Folate Testing
- G2155 General Inflammation Testing
- G2156 Urine Culture Testing for Bacteria
- G2157 Diagnostic Testing of Common Sexually Transmitted Infections
- G2158 Testing for Mosquito- or Tick-Related Infections
- G2159 B-Hemolytic Streptococcus Testing
- G2164 Parathyroid Hormone Phosphorus Calcium and Magnesium Testing
- G2173 Gamma-Glutamyl Transferase
- G2174 Coronavirus Testing in the Outpatient Setting
- G2181 Colorectal Cancer Screening
- M2041 Venous and Arterial Thrombosis Risk Testing
- M2057 Diagnosis of Vaginitis including Multi-target PCR Testing
- M2068 Testing for Alpha-1 Antitrypsin Deficiency
- M2097 Identification Of Microorganisms Using Nucleic Acid Probes
- M2112 Nerve Fiber Density Testing
- M2116 Plasma HIV-1 and HIV-2 RNA Quantification for HIV Infection
- M2141 Testing of Homocysteine Metabolism-Related Conditions
- M2172 Onychomycosis Testing
- M2176 Testing for Autism Spectrum Disorders and Developmental Delay
- P2018 Immunohistochemistry
- T2015 Prescription Medication and Illicit Drug Testing in the Outpatient Setting
Content from General Links with modal content